Management of Ongoing Anxiety in Alcohol Withdrawal
Medication Options for Persistent Anxiety in Alcohol Withdrawal
- The British Medical Journal recommends administering lorazepam 1 mg IV or SC (up to 2 mg maximum) as the next medication of choice for a patient with alcohol withdrawal experiencing persistent anxiety after receiving diazepam 5 mg 1, 2
- Lorazepam 1 mg IV/SC/PO is the preferred next option when diazepam has been insufficient, with a shorter half-life than diazepam, and can be given sublingually if the oral route is available 1, 3
- Lower doses (0.25-0.5 mg) of lorazepam should be used in elderly, frail patients, or those with respiratory conditions 1
- The maximum single dose of lorazepam is 2 mg, and it can be repeated as needed for symptom control 1
- Midazolam 2.5 mg SC/IV is an alternative option for rapid control of severe anxiety or agitation when lorazepam is unavailable, and can be given up to q1h PRN (maximum 5 mg per dose) 4, 3, 5
Clinical Approach to Persistent Anxiety in Alcohol Withdrawal
- The Journal of Hepatology suggests evaluating vital signs to assess for worsening withdrawal symptoms, and using the CIWA-Ar scale if available (scores >8 indicate moderate withdrawal, ≥15 indicate severe withdrawal) 2, 6, 7
- Checking for signs of delirium or hallucinations that may require antipsychotic addition is recommended 5, 3
Important Considerations and Precautions
- Benzodiazepines remain the gold standard for alcohol withdrawal management, with symptom-triggered regimens preferred over fixed schedules to prevent drug accumulation 2, 6
- Monitoring closely for oversedation when administering additional benzodiazepines, especially in patients with respiratory conditions or when combining with antipsychotics, is crucial 4, 5
- Caution should be exercised in specific populations, including elderly or frail patients, who should receive lower doses (lorazepam 0.25-0.5 mg), and those with hepatic impairment, who should prefer lorazepam over additional diazepam 1, 3
- The Annals of Oncology warns against combining high-dose olanzapine with benzodiazepines due to the risk of fatal respiratory depression, and against prolonged benzodiazepine use beyond 10-14 days due to the risk of dependence 4, 3, 6, 7